openPR Logo
Press release

Spotlight sessions at the upcoming Lyophilization USA Conference

10-02-2018 03:14 PM CET | Health & Medicine

Press release from: SMi Group

Spotlight sessions at the upcoming Lyophilization USA

Lyophilization is one of the most time consuming and expensive unit operations. There are many issues within lyopilization which need addressing, and improved drying technologies are needed for current and future products.

Featuring an exceptional line-up of keynote speakers from industry leading organisations, SMi's 4th Lyophilization USA conference arrives at the perfect time to discuss novel techniques and advances; regulatory and freeze-drying challenges; finally, alternatives to conventional methods.

Agenda highlights will include a spotlight on novel PAT and QbD principles, scale up and technology transfer, bulk lyophilization, and assessing phase separation in lyophilized protein formulation.

Comparing and contrasting two methods of controlled nucleation for use in lyophilization: A live viral vaccine (LVV) perspective

• Evaluation of two methods of controlled nucleation: pressurization / depressurization technology and “ice-fog” technology
• Can controlled nucleation impart consistency whilst maintaining vaccine potency?
• Impact on cycle time, consistency and moisture levels
Morrisa Jones, Senior Scientist, Vaccine Drug Product Development, Merck & Co., Inc.

Freeze dryer characterization and application to drug product development and scale up
• Characterization of bench, pilot and industrial scale freeze dryers
• Product characterization & measurement of Rp
• Application of models to the development of a lyophilization cycle
• Scale up
• PAT applications to development and scale up
Timothy McCoy, Associate Director, Pharmaceutical Development, Biologics Research and Development, Sanofi

Challenges of lyophilized product development
• Formulation challenges
- Excipients selection
- Dosage forms: solution, suspension, & oral melt
- Route of administration: iv, im and oral
- Solvents: aqueous and non-aqueous
- API: biologics & small molecules
• Process challenges
• Device selections
Yanming Zu, Director, Research and Development, Abon Pharmaceuticals

Download the brochure for a detailed program

For media enquiries, contact Jinna Sidhu on +44 (0) 20 7827 0688 or hsidhu@smi-online.co.uk

Conference: November 15 - 16, 2018
Workshops: November 14, 2018
Venue: Renaissance Woodbridge Hotel, New Jersey, USA
Website: www.lyophilization-usa.com/pr

Follow us @SMIpharm
Tag us #lyousa

---- ENDS ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Ground & First Floor 1 Westminster Bridge Road London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Spotlight sessions at the upcoming Lyophilization USA Conference here

News-ID: 1275257 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Lyophilization

Lyophilization Services for Biopharmaceuticals Market - CNS Pharmaceuticals, Jub …
Lyophilization Services for Biopharmaceuticals Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Lyophilization Services for Biopharmaceuticals industry overview and then goes into each and every detail. Lyophilization Services for Biopharmaceuticals Market Report contains in depth information major manufacturers, opportunities, challenges, and industry trends and their impact on the market forecast. Lyophilization Services for Biopharmaceuticals also provides data about the company and its
Achieving Controlled Nucleation During Aseptic Lyophilization
Controlled nucleation is essential for obtaining high-quality lyophilized products with intra- and inter-batch consistency. Two approaches to achieving controlled nucleation have been investigated recently: creating a pressure differential and using an ice fog to insert seed crystals into the vials within the lyophilization chamber. Morrisa Jones, Senior Scientist, Vaccine Drug Product Development Merck, who is speaking at the SMi’s Groups’ Lyophilization USA Conference she will be comparing and contrasting two
Exclusive insight from experts in the lyophilization industry
SMi Group reports: Leaders in the lyophilization industry to share their expertise and knowledge at SMi’s 4th annual conference - Lyophilization USA, November 15 - 16, New Jersey. Recently, event organisers caught up with some of them to discuss key challenges within the lyophilization field. A brief overview from Q&A sessions with: • Fabrice Schlegel - Senior Engineer at Amgen • Mohamed AbouGhaly - Postdoctoral Researcher at Purdue University • Timothy McCoy, Associate Director, Pharmaceutical Development Biologics
Lyophilization USA Conference – official agenda published
SMi Group reports: exploring the future of lyophilization at the established event this November Building on knowledge and experience of the market, SMi Group is pleased to announce the release of the official agenda for the 4th annual Lyophilization USA Conference, which is due to take place in Iselin, New Jersey on November 15 - 16, 2018. Lyophilization is one of the most time-consuming and expensive operations, and improved drying technologies are
Final Reminder: 1 Week Until SMi’s Lyophilization USA
With the event now just 1 week away, a gentle reminder that there is still time to secure your place at SMi's 3rd annual event, Lyophilization USA, taking place on November 16th and 17th in Iselin, New Jersey. Looking to create a competitive edge, reduce manufacturing costs and shorten cycle time through understanding key parameters in pharmaceutical freeze-drying? Receive guidance on QbD submissions? Gain an overview of the latest innovations
Updates in Cutting Edge Lyophilization Technology
Product temperature is the most important critical quality attribute in a freeze-drying process. During the process, product temperature cannot be controlled directly, but is determined by a combination of process and product parameters. The shelf temperature and chamber pressure are controlled directly based on the user-defined recipe, and constitute the main variables for achieving a suitable product temperature over time profile. Further parameters influence the product temperature as well, such as